Professor Joseph Pagano, BW Fund

Prof Pagano collaborated with Elion re the effects of acyclovir on the Epstein Bar virus. The interview focuses on the scientific and research aspects of the company.

Topics disucssed include:

* Fred Coe

* Pedro Cuatrecasas: work; relationship with Bill Sullivan; departure from BW; career with Glaxo and then Warner-Lambert;

* David Barry: changes within structure of department; work

* merger with Glaxo, nature of BW before merger

* acyclovir - marketing and development

* development of Retrovir and AZT, future of anti-HIV[Aids] therapy

11 May 2001

audio tape and transcript Tape 22 side B

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.